Hwanin Pharmaceutical
KOSPI · Healthcare · ₩192B
₩10,300-0.29%
Price
10,240원
10,300원
Jun 15, 26Sep 11, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue₩68.8B-3.7%
Operating Income₩4.8B-39.2%
6/'26 vs prev quarter
Company Health
Market Cap₩192B
Operating Margin+8.2%
Cash on Hand664억원34.6% of market cap
Free Cash Flow150억원7.8% of market cap
Short Volume 1.1% · as of 26.09.11
Among 98 제약 peers
LowMedianHigh
PSR0.7xmedian 0.8xPER9.4xmedian 10.7xPBR0.5xmedian 0.8xROE+4.8%median +4.9%
